Crestline Management, LP Vista Gen Therapeutics, Inc. Transaction History
Crestline Management, LP
- $1.28 Billion
- Q2 2024
A detailed history of Crestline Management, LP transactions in Vista Gen Therapeutics, Inc. stock. As of the latest transaction made, Crestline Management, LP holds 350,000 shares of VTGN stock, worth $1.14 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
350,000Holding current value
$1.14 Million% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VTGN
# of Institutions
2Shares Held
2.7MCall Options Held
0Put Options Held
0About VistaGen Therapeutics, Inc.
- Ticker VTGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 206,836,000
- Market Cap $672M
- Description
- VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...